Personalized Skin Rejuvenation System with Integrated AI, IoT, and Blockchain Technologies
Legal Citation
Summary of the Inventive Concept
A synergistic system combining modified hyaluronate compositions with AI-powered skin analysis, IoT-enabled real-time skin hydration monitoring, and blockchain-based secure data storage and supply chain management for personalized and effective skin rejuvenation treatments.
Background and Problem Solved
The original patent disclosed a method for making modified hyaluronate compositions for soft tissue fillers. However, the patent did not address the limitations of manual skin analysis, lack of personalized treatment plans, and inadequate data tracking and supply chain management. The new inventive concept integrates distinct technologies to create a comprehensive system for personalized skin rejuvenation, overcoming these limitations.
Detailed Description of the Inventive Concept
The system comprises a modified hyaluronate composition made by the method of claim 1, integrated with an AI-powered skin analysis module for identifying optimal injection sites and dosages. The AI module uses machine learning algorithms to analyze patient-specific skin characteristics and generate personalized treatment plans. Additionally, a wearable IoT device monitors skin hydration levels in real-time, transmitting data to a cloud-based server for analysis and personalized recommendations. The system also includes a blockchain-based secure data storage system for tracking patient treatment records and a decentralized ledger for recording transactions and product authenticity in the dermal filler supply chain.
Novelty and Inventive Step
The new claims introduce a synergistic combination of AI, IoT, and blockchain technologies with the modified hyaluronate composition, providing a non-obvious and novel solution for personalized skin rejuvenation. The integration of these distinct technologies enables a more effective, efficient, and secure system for skin rejuvenation treatments.
Alternative Embodiments and Variations
Alternative embodiments may include using different machine learning algorithms or AI models for skin analysis, incorporating additional sensors or data sources into the IoT device, or utilizing different blockchain platforms for secure data storage and supply chain management. Variations may also include adapting the system for use in other aesthetic or medical applications, such as facial reconstruction or wound healing.
Potential Commercial Applications and Market
The personalized skin rejuvenation system has significant commercial potential in the aesthetics and dermatology industries, with a growing market demand for effective and personalized skin rejuvenation treatments. The system's integration of AI, IoT, and blockchain technologies also opens up opportunities for partnerships and collaborations with technology companies, pharmaceutical companies, and medical device manufacturers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/1652 |
| A | A61 | A61K8/735 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K9/06 |
| A | A61 | A61K9/1658 |
| A | A61 | A61K31/167 |
| A | A61 | A61K47/42 |
| A | A61 | A61Q19/08 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomaterials and Aesthetic Medicine, specifically focused on hyaluronic acid-based soft tissue fillers and advanced medical technologies involving dermatological treatments and personalized medical systems
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biomedical engineering, materials science, or pharmaceutical sciences, possessing expertise in biomaterial formulations, medical device integration, and digital health technologies, with knowledge of machine learning, IoT, and blockchain applications in medical contexts
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with established hyaluronate compositions represents a predictable extension of existing medical innovation strategies. The combination of AI-powered analysis, IoT monitoring, and blockchain tracking with a known hyaluronate formulation represents an obvious application of emerging technologies to enhance medical treatment personalization and tracking. The technical elements are well-established in their respective domains and their integration would be a logical progression for improving medical treatment efficacy and patient outcomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,682 |
|---|---|
| Title | Hyaluronate compositions and soft tissue fillers |
| Assignee(s) | AMC |